Samuel Agresta - 27 Jan 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
Chief Medical Officer
Signature
/s/ Rogan Nunn, by power of attorney
Issuer symbol
OKUR
Transactions as of
27 Jan 2025
Transactions value $
$0
Form type
4
Filing time
29 Jan 2025, 20:33:11 UTC
Previous filing
08 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OKUR Employee Stock Option (right to buy) Award $0 +45,000 $0 45,000 27 Jan 2025 Class A Common Stock 45,000 $5.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option shall vest on February 27, 2025 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.